AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by AEON Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $243.5K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$243.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for AEON Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lynch Timothy P | 10% Owner | 6,500,000 | Aug 21, 2026 | 1 |
| Palmisano Robert J | Director | 258,705 | Jun 22, 2026 | 1 |
| Thunen Shelley B | Director | 258,705 | Jun 22, 2026 | 1 |
| Fischer Jost | Director | 489,469 | Jun 22, 2026 | 1 |
| Carter Eric G | Director | 258,705 | Jun 22, 2026 | 1 |
| Forth Marc | Director | 973,231 | Jun 22, 2026 | 1 |
| Bencich John | CHIEF FINANCIAL OFFICER | 754,717 | Apr 3, 2026 | 1 |
| Oh Chad | CHIEF MEDICAL OFFICER | 2,183,436 | Mar 11, 2026 | 1 |
| Wilson Alexander Blair | CLO, CSO, and Corp Secretary | 2,183,005 | Mar 5, 2026 | 1 |
| Sy Jennifer | PRINCIPAL ACCOUNTING OFFICER | 1,501,176 | Mar 5, 2026 | 1 |
| Bancroft Robert E. | PRESIDENT & CEO | 3,177,103 | Feb 19, 2026 | 1 |
| Daewoong Co., Ltd | 10% Owner | – | Apr 16, 2024 | 0 |
| Strathspey Crown Holdings Group, LLC | 10% Owner | 2,031,773 | Aug 14, 2023 | 0 |
| Malik Vikram | 10% Owner | 6,989,163Indirect | Jul 26, 2023 | 0 |
| Priveterra Sponsor, LLC | 10% Owner | 6,989,163Indirect | Jul 26, 2023 | 0 |
| Grodnensky Oleg | 10% Owner | 6,989,163Indirect | Jul 26, 2023 | 0 |
| Barclays PLC | 10% Owner | – | Mar 31, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)7:41 PM ET | Aug 19 | 2 days | Lynch Timothy P10% Owner | PPurchaseClass A Common Stock | +1.15M | $0.2117 | +$243.5K | +21.5%6.50M after | |
| May 23, 2025 (view filing)4:46 PM ET | May 21 | 2 days | Fischer JostDirector | PPurchaseClass A Common Stock | +60.0K | $0.4875 | +$29.3K | +29.0%266.8K after | |
| May 21, 2025 (view filing) | May 19-20 | 2 days | Fischer JostDirector | PPurchaseClass A Common Stock | +110.0K | $0.5055 | +$55.6K | +113.7%206.8K after | 2 lots |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Strathspey Crown Holdings Group, LLC10% Owner | SSaleClass A Common Stock | −7.38M | $10.00 | −$73.8M | −78.4%2.03M after |